Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001567619-21-014751
Filing Date
2021-08-09
Accepted
2021-08-09 16:40:19
Documents
1
Period of Report
2021-08-05

Document Format Files

Seq Description Document Type Size
1 FORM 4 doc1.html 4  
1 FORM 4 doc1.xml 4 3926
  Complete submission text file 0001567619-21-014751.txt   5379
Mailing Address 7380 COCA COLA DRIVE SUITE 106 HANOVER MD 21076
Business Address 7380 COCA COLA DRIVE SUITE 106 HANOVER MD 21076 443-776-3133
Processa Pharmaceuticals, Inc. (Issuer) CIK: 0001533743 (see all company filings)

EIN.: 451539785 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 7380 COCA COLA DRIVE SUITE 106 HANOVER MD 21076
Business Address
Bigora Sian (Reporting) CIK: 0001799365 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39531 | Film No.: 211157090